112 related articles for article (PubMed ID: 33130177)
1. M-Ras is Muscle-Ras, Moderate-Ras, Mineral-Ras, Migration-Ras, and Many More-Ras.
Endo T
Exp Cell Res; 2020 Dec; 397(1):112342. PubMed ID: 33130177
[TBL] [Abstract][Full Text] [Related]
2. SHOC2-MRAS-PP1 complex positively regulates RAF activity and contributes to Noonan syndrome pathogenesis.
Young LC; Hartig N; Boned Del Río I; Sari S; Ringham-Terry B; Wainwright JR; Jones GG; McCormick F; Rodriguez-Viciana P
Proc Natl Acad Sci U S A; 2018 Nov; 115(45):E10576-E10585. PubMed ID: 30348783
[TBL] [Abstract][Full Text] [Related]
3. MRAS: A Close but Understudied Member of the RAS Family.
Young LC; Rodriguez-Viciana P
Cold Spring Harb Perspect Med; 2018 Dec; 8(12):. PubMed ID: 29311130
[TBL] [Abstract][Full Text] [Related]
4. Structure of the SHOC2-MRAS-PP1C complex provides insights into RAF activation and Noonan syndrome.
Bonsor DA; Alexander P; Snead K; Hartig N; Drew M; Messing S; Finci LI; Nissley DV; McCormick F; Esposito D; Rodriguez-Viciana P; Stephen AG; Simanshu DK
Nat Struct Mol Biol; 2022 Oct; 29(10):966-977. PubMed ID: 36175670
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into the role of SHOC2-MRAS-PP1C complex in RAF activation.
Bonsor DA; Simanshu DK
FEBS J; 2023 Oct; 290(20):4852-4863. PubMed ID: 37074066
[TBL] [Abstract][Full Text] [Related]
6. M-Ras/Shoc2 signaling modulates E-cadherin turnover and cell-cell adhesion during collective cell migration.
Kota P; Terrell EM; Ritt DA; Insinna C; Westlake CJ; Morrison DK
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3536-3545. PubMed ID: 30808747
[TBL] [Abstract][Full Text] [Related]
7. Structure of the MRAS-SHOC2-PP1C phosphatase complex.
Hauseman ZJ; Fodor M; Dhembi A; Viscomi J; Egli D; Bleu M; Katz S; Park E; Jang DM; Porter KA; Meili F; Guo H; Kerr G; Mollé S; Velez-Vega C; Beyer KS; Galli GG; Maira SM; Stams T; Clark K; Eck MJ; Tordella L; Thoma CR; King DA
Nature; 2022 Sep; 609(7926):416-423. PubMed ID: 35830882
[TBL] [Abstract][Full Text] [Related]
8. M-Ras evolved independently of R-Ras and its neural function is conserved between mammalian and ascidian, which lacks classical Ras.
Keduka E; Kaiho A; Hamada M; Watanabe-Takano H; Takano K; Ogasawara M; Satou Y; Satoh N; Endo T
Gene; 2009 Jan; 429(1-2):49-58. PubMed ID: 18977283
[TBL] [Abstract][Full Text] [Related]
9. Severe Noonan syndrome phenotype associated with a germline Q71R MRAS variant: a recurrent substitution in RAS homologs in various cancers.
Suzuki H; Takenouchi T; Uehara T; Takasago S; Ihara S; Yoshihashi H; Kosaki K
Am J Med Genet A; 2019 Aug; 179(8):1628-1630. PubMed ID: 31173466
[TBL] [Abstract][Full Text] [Related]
10. An MRAS, SHOC2, and SCRIB complex coordinates ERK pathway activation with polarity and tumorigenic growth.
Young LC; Hartig N; Muñoz-Alegre M; Oses-Prieto JA; Durdu S; Bender S; Vijayakumar V; Vietri Rudan M; Gewinner C; Henderson S; Jathoul AP; Ghatrora R; Lythgoe MF; Burlingame AL; Rodriguez-Viciana P
Mol Cell; 2013 Dec; 52(5):679-92. PubMed ID: 24211266
[TBL] [Abstract][Full Text] [Related]
11. SHOC2 complex-driven RAF dimerization selectively contributes to ERK pathway dynamics.
Boned Del Río I; Young LC; Sari S; Jones GG; Ringham-Terry B; Hartig N; Rejnowicz E; Lei W; Bhamra A; Surinova S; Rodriguez-Viciana P
Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13330-13339. PubMed ID: 31213532
[TBL] [Abstract][Full Text] [Related]
12. Structure-function analysis of the SHOC2-MRAS-PP1C holophosphatase complex.
Kwon JJ; Hajian B; Bian Y; Young LC; Amor AJ; Fuller JR; Fraley CV; Sykes AM; So J; Pan J; Baker L; Lee SJ; Wheeler DB; Mayhew DL; Persky NS; Yang X; Root DE; Barsotti AM; Stamford AW; Perry CK; Burgin A; McCormick F; Lemke CT; Hahn WC; Aguirre AJ
Nature; 2022 Sep; 609(7926):408-415. PubMed ID: 35831509
[TBL] [Abstract][Full Text] [Related]
13. A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity.
Rodriguez-Viciana P; Oses-Prieto J; Burlingame A; Fried M; McCormick F
Mol Cell; 2006 Apr; 22(2):217-30. PubMed ID: 16630891
[TBL] [Abstract][Full Text] [Related]
14. A novel rasopathy caused by recurrent de novo missense mutations in PPP1CB closely resembles Noonan syndrome with loose anagen hair.
Gripp KW; Aldinger KA; Bennett JT; Baker L; Tusi J; Powell-Hamilton N; Stabley D; Sol-Church K; Timms AE; Dobyns WB
Am J Med Genet A; 2016 Sep; 170(9):2237-47. PubMed ID: 27264673
[TBL] [Abstract][Full Text] [Related]
15. The molecular functions of RIT1 and its contribution to human disease.
Van R; Cuevas-Navarro A; Castel P; McCormick F
Biochem J; 2020 Aug; 477(15):2755-2770. PubMed ID: 32766847
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for SHOC2 modulation of RAS signalling.
Liau NPD; Johnson MC; Izadi S; Gerosa L; Hammel M; Bruning JM; Wendorff TJ; Phung W; Hymowitz SG; Sudhamsu J
Nature; 2022 Sep; 609(7926):400-407. PubMed ID: 35768504
[TBL] [Abstract][Full Text] [Related]
17. The Role of R-Ras Proteins in Normal and Pathologic Migration and Morphologic Change.
Weber SM; Carroll SL
Am J Pathol; 2021 Sep; 191(9):1499-1510. PubMed ID: 34111428
[TBL] [Abstract][Full Text] [Related]
18. Sustained activation of M-Ras induced by nerve growth factor is essential for neuronal differentiation of PC12 cells.
Sun P; Watanabe H; Takano K; Yokoyama T; Fujisawa J; Endo T
Genes Cells; 2006 Sep; 11(9):1097-113. PubMed ID: 16923128
[TBL] [Abstract][Full Text] [Related]
19. Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway.
Tidyman WE; Rauen KA
Expert Rev Mol Med; 2008 Dec; 10():e37. PubMed ID: 19063751
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromatosis-Noonan syndrome: case report and clinicopathogenic review of the Neurofibromatosis-Noonan syndrome and RAS-MAPK pathway.
Reig I; Boixeda P; Fleta B; Morenoc C; Gámez L; Truchuelo M
Dermatol Online J; 2011 Apr; 17(4):4. PubMed ID: 21549079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
